• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对 1,2,3-三唑基甾体进行系统研究,开发治疗寄生虫性被忽视热带病的新药。

Systematic study of 1,2,3-triazolyl sterols for the development of new drugs against parasitic Neglected Tropical Diseases.

机构信息

Instituto de Química Rosario (IQUIR-CONICET), Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 531, S2002LRK, Rosario, Argentina.

Queen Mary University of London, Mile End Road, London, E1 4NS, UK.

出版信息

Eur J Med Chem. 2023 Jun 5;254:115378. doi: 10.1016/j.ejmech.2023.115378. Epub 2023 Apr 13.

DOI:10.1016/j.ejmech.2023.115378
PMID:37084599
Abstract

A series of thirty 1,2,3-triazolylsterols, inspired by azasterols with proven antiparasitic activity, were prepared by a stereocontrolled synthesis. Ten of these compounds constitute chimeras/hybrids of 22,26-azasterol (AZA) and 1,2,3-triazolyl azasterols. The entire library was assayed against the kinetoplastid parasites Leishmania donovani, Trypanosoma cruzi, and Trypanosoma brucei, the causatives agents for visceral leishmaniasis, Chagas disease, and sleeping sickness, respectively. Most of the compounds were active at submicromolar/nanomolar concentrations with high selectivity index, when compared to their cytotoxicity against mammalian cells. Analysis of in silico physicochemical properties were conducted to rationalize the activities against the neglected tropical disease pathogens. The analogs with selective activity against L. donovani (E4, IC 0.78 μM), T brucei (E1, IC 0.12 μM) and T. cruzi (B1- IC 0.33 μM), and the analogs with broad-spectrum antiparasitic activities against the three kinetoplastid parasites (B1 and B3), may be promising leads for further development as selective or broad-spectrum antiparasitic drugs.

摘要

受具有已证实抗寄生虫活性的氮杂甾醇的启发,我们通过立体控制合成制备了一系列三十个 1,2,3-三唑基甾醇。其中十种化合物是 22,26-氮杂甾醇(AZA)和 1,2,3-三唑基氮杂甾醇的嵌合体/杂种。整个化合物库针对引起内脏利什曼病、恰加斯病和昏睡病的克氏锥虫、锥虫和利什曼原虫进行了测试。与对哺乳动物细胞的细胞毒性相比,大多数化合物在亚微摩尔/纳摩尔浓度下具有高选择性指数的活性。对化合物进行了计算物理化学性质分析,以合理阐明其对被忽视的热带病病原体的活性。对 L. donovani(E4,IC 0.78 μM)、T. brucei(E1,IC 0.12 μM)和 T. cruzi(B1-IC 0.33 μM)具有选择性活性的类似物,以及对三种锥虫具有广谱抗寄生虫活性的类似物(B1 和 B3),可能是进一步开发作为选择性或广谱抗寄生虫药物的有前途的先导化合物。

相似文献

1
Systematic study of 1,2,3-triazolyl sterols for the development of new drugs against parasitic Neglected Tropical Diseases.对 1,2,3-三唑基甾体进行系统研究,开发治疗寄生虫性被忽视热带病的新药。
Eur J Med Chem. 2023 Jun 5;254:115378. doi: 10.1016/j.ejmech.2023.115378. Epub 2023 Apr 13.
2
In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.芳基取代咪唑衍生物作为抗原生动物药物的体外评价以及对克氏锥虫、婴儿利什曼原虫和布氏锥虫的甾醇14α-脱甲基酶(CYP51)的对接研究。
Parasitol Res. 2019 May;118(5):1533-1548. doi: 10.1007/s00436-019-06206-z. Epub 2019 Mar 23.
3
Screening a Natural Product-Based Library against Kinetoplastid Parasites.抗锥虫天然产物文库的筛选。
Molecules. 2017 Oct 12;22(10):1715. doi: 10.3390/molecules22101715.
4
Design and preparation of sterol mimetics as potential antiparasitics.作为潜在的抗寄生虫药物的固醇类似物的设计与制备。
Bioorg Med Chem. 2010 Oct 15;18(20):7291-301. doi: 10.1016/j.bmc.2010.08.007. Epub 2010 Aug 9.
5
Design, Synthesis and Antiparasitic Evaluation of Click Phospholipids.点击型磷脂的设计、合成与抗寄生虫评估
Molecules. 2021 Jul 10;26(14):4204. doi: 10.3390/molecules26144204.
6
The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.重新审视动基体化疗:现有药物、最新进展及未来展望。
Curr Med Chem. 2010;17(33):4027-51. doi: 10.2174/092986710793205345.
7
Exploring microalgal and cyanobacterial metabolites with antiprotozoal activity against Leishmania and Trypanosoma parasites.探索对利什曼原虫和锥虫寄生虫具有抗原生动物活性的微藻和蓝藻代谢产物。
Acta Trop. 2024 Mar;251:107116. doi: 10.1016/j.actatropica.2023.107116. Epub 2023 Dec 28.
8
Overview of the role of kinetoplastid surface carbohydrates in infection and host cell invasion: prospects for therapeutic intervention.动基体表面碳水化合物在感染和宿主细胞入侵中的作用概述:治疗干预的前景。
Parasitology. 2019 Dec;146(14):1743-1754. doi: 10.1017/S0031182019001355. Epub 2019 Oct 11.
9
The Role of Flavanones as Scaffolds for the Development of New Treatments against Malaria and African and American Trypanosomiases.类黄酮作为开发抗疟疾和非洲及美洲锥虫病新疗法的支架的作用。
Mini Rev Med Chem. 2023;23(14):1479-1498. doi: 10.2174/1389557523666221229122543.
10
SAR studies on azasterols as potential anti-trypanosomal and anti-leishmanial agents.氮杂甾体作为潜在抗锥虫和抗利什曼原虫药物的构效关系研究。
Bioorg Med Chem. 2009 Aug 15;17(16):5950-61. doi: 10.1016/j.bmc.2009.06.062. Epub 2009 Jul 3.

引用本文的文献

1
Lewis acid-promoted intramolecular cyclization of -prenylated chalcones: application to first total synthesis of (±) involucrasin C and its novel analogues.路易斯酸促进的γ-异戊烯基查耳酮的分子内环化反应:应用于(±)内卷素C及其新型类似物的首次全合成
RSC Adv. 2025 Jul 31;15(33):27254-27259. doi: 10.1039/d5ra04830c. eCollection 2025 Jul 25.
2
Progress and Prospects of Triazoles in Advanced Therapies for Parasitic Diseases.三唑类药物在寄生虫病先进治疗方法中的进展与前景
Trop Med Infect Dis. 2025 May 20;10(5):142. doi: 10.3390/tropicalmed10050142.
3
Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities.
探索恰加斯病的药物再利用:进展、挑战与机遇。
Front Pharmacol. 2023 Jul 27;14:1233253. doi: 10.3389/fphar.2023.1233253. eCollection 2023.